PE62399A1 - Aplicacion oral de (+)-o-demetiltramadol como analgesico - Google Patents

Aplicacion oral de (+)-o-demetiltramadol como analgesico

Info

Publication number
PE62399A1
PE62399A1 PE1998000210A PE00021098A PE62399A1 PE 62399 A1 PE62399 A1 PE 62399A1 PE 1998000210 A PE1998000210 A PE 1998000210A PE 00021098 A PE00021098 A PE 00021098A PE 62399 A1 PE62399 A1 PE 62399A1
Authority
PE
Peru
Prior art keywords
demetiltramadol
analgesic
oral application
refers
acids
Prior art date
Application number
PE1998000210A
Other languages
English (en)
Inventor
Elmar Josef Friderichs
Werner Winter
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of PE62399A1 publication Critical patent/PE62399A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A (+)-O-DEMETILTRAMADOL COMO BASE LIBRE Y/O SU SAL. SUS SALES SE FORMAN CON ACIDOS ORGANICOS PARTICULARMENTE ACIDOS GRASOS C8-C22 Y ACIDOS CARBOXILICOS AROMATICOS. TAMBIEN SE REFIERE A SU UTILIZACION EN FORMA DE TABLETAS DE MATRIZ CON LIBERACION RETARDADA DE LA SUSTANCIA ACTIVA; EL FORMADOR DE DICHA MATRIZ ESTA CONSTITUIDO POR AL MENOS UN ETER O ESTER DE CELULOSA DE PREFERENCIA METILHIDROXIPROPILCELULOSA, HIDROXIMETILCELULOSA, ENTRE OTROS. EL (+)-O-DEMETILTRAMADOL PUEDE SER UTIL EN EL TRATAMIENTO DE ALGIAS INTENSAS, AGUDAS Y/O CRONICAS
PE1998000210A 1997-03-25 1998-03-24 Aplicacion oral de (+)-o-demetiltramadol como analgesico PE62399A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712398A DE19712398A1 (de) 1997-03-25 1997-03-25 Orale Anwendung von (+)-0-Demethyltramadol als Schmerzmittel

Publications (1)

Publication Number Publication Date
PE62399A1 true PE62399A1 (es) 1999-07-10

Family

ID=7824498

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000210A PE62399A1 (es) 1997-03-25 1998-03-24 Aplicacion oral de (+)-o-demetiltramadol como analgesico

Country Status (14)

Country Link
EP (1) EP0870499A1 (es)
JP (1) JPH1112166A (es)
KR (1) KR19980080580A (es)
CN (1) CN1196932A (es)
AU (1) AU5951798A (es)
BR (1) BR9801839A (es)
CA (1) CA2232930A1 (es)
DE (1) DE19712398A1 (es)
HU (1) HUP9800623A3 (es)
IL (1) IL123788A0 (es)
NO (1) NO981320L (es)
PE (1) PE62399A1 (es)
PL (1) PL325509A1 (es)
UY (1) UY24934A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20010623A1 (es) * 1999-10-05 2001-07-07 Gruenenthal Chemie Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria
DE10108123A1 (de) * 2001-02-21 2002-10-02 Gruenenthal Gmbh Wirkstoffkombination
WO2011110595A1 (de) 2010-03-10 2011-09-15 Grünenthal GmbH Kristalline salze und/oder cokristalle von o-desmethyltramadol
US10702485B2 (en) 2011-07-09 2020-07-07 Syntrix Biosystems Inc. Compositions and methods for overcoming resistance to tramadol

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9205106A (es) * 1991-09-06 1993-05-01 Johnson & Johnson Composiciones que comprenden un material de tramadol y cualquiera de codeina, oxicodona o hidrocodona y su uso
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
DE4315525B4 (de) * 1993-05-10 2010-04-15 Euro-Celtique S.A. Pharmazeutische Zusammensetzung
DE4329794C2 (de) * 1993-09-03 1997-09-18 Gruenenthal Gmbh Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
DE19601744C2 (de) * 1996-01-19 1998-04-16 Gruenenthal Gmbh Verfahren zur Herstellung der Enantiomeren von O-Demethyltramadol

Also Published As

Publication number Publication date
CN1196932A (zh) 1998-10-28
NO981320L (no) 1998-09-28
KR19980080580A (ko) 1998-11-25
HUP9800623A3 (en) 1999-03-29
HU9800623D0 (en) 1998-05-28
UY24934A1 (es) 1998-04-21
PL325509A1 (en) 1998-09-28
CA2232930A1 (en) 1998-09-25
AU5951798A (en) 1998-10-01
DE19712398A1 (de) 1998-10-01
NO981320D0 (no) 1998-03-24
BR9801839A (pt) 2000-01-18
HUP9800623A2 (hu) 1999-01-28
EP0870499A1 (de) 1998-10-14
JPH1112166A (ja) 1999-01-19
IL123788A0 (en) 1998-10-30

Similar Documents

Publication Publication Date Title
ES2581574T3 (es) Sistema terapéutico transdérmico para la administración del principio activo buprenorfina
PT1392295E (pt) Derivados de oxazole substituidos por acidos carboxilicos para serem utilizados como activadores de rapp alfa e gama no tratamento de diabetes
ES2194536T3 (es) Combinacion de duloxetina con farmacos antiinflamatorios no esteroideos.
PE20001646A1 (es) BIFENILO QUE CONTIENEN COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE aP2
EA200300634A1 (ru) Фармацевтическая композиция, содержащая действующее вещество, диспергированное в матрице
BR9911981A (pt) Esparadrapo tópico com anti-reumático não esteroidal com grupo ácido
ES2162517T3 (es) Composicion farmaceutica que comprende una combinacion de metformin y fibrato y su uso en la preparacion de medicamentos destinados a reducir la hiperglicemia.
AR064895A2 (es) Composicion farmaceutica anhidra para el tratamiento de desordenes inducidos por histamina
ES2196502T3 (es) Composicion y metodo para inhibir el desarrollo de microorganismos que incluye hipobromito sodico estabilizado e isotiazolonas.
KR950031058A (ko) 경피 흡수 제제
CY1108700T1 (el) Συνθεσεις απελευθερωσης φαρμακου εστερα αλφα-υδροξυ οξεος και μεθοδοι χρησης
MY128021A (en) Sheet with oil ingredient-containing layer
ATE89819T1 (de) Gegebenenfalls alpha-substituierte 4-(chinolin-2- yl-methoxy)phenylessigsaeuren und -ester.
CY1108250T1 (el) Διαδερμικο θεραπευτικο συστημα για τη χορηγηση μη στεροειδικων αντιφλογιστικων που φερουν καρβοξυλομαδες, καθως και μεθοδος για την παραγωγη του
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
PE20151147A1 (es) Sistema de liberacion transdermica
BRPI0512649A (pt) artigos moldados sólidos contendo substáncias ativas para uso externo no combate a parasitas em animais
FI863976A0 (fi) Terapeutisk komposition.
AR046210A1 (es) Preparacion solida
CO4910117A1 (es) Composicion de administracion oral con liberacion controlada de al menos un analgesico
PE62399A1 (es) Aplicacion oral de (+)-o-demetiltramadol como analgesico
PT977560E (pt) Tioesteres de ibuprofeno como inibidores de formacao de mediadores de inflamacaoe da dor dependente de nf-kb
PE20001325A1 (es) Combinacion de cerivastatina y fibratos
RU2006119610A (ru) Фармацевтический препарат абсорбционного типа для чрезкожного введения
GT200100145A (es) Derivados de pirrolidina.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal